| Crizanlizumab for the prevention of pain crises in sickle cell disease KI Ataga, A Kutlar, J Kanter, D Liles, R Cancado, J Friedrisch, TH Guthrie, ... New England Journal of Medicine 376 (5), 429-439, 2017 | 820 | 2017 |
| Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia MP Colella, EV De Paula, N Conran, JA Machado‐Neto, ... Journal of Thrombosis and Haemostasis 10 (9), 1967-1970, 2012 | 54 | 2012 |
| Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias FLB Ferreira, MP Colella, SS Medina, C Costa-Lima, MML Fiusa, ... Scientific reports 7 (1), 3355, 2017 | 53 | 2017 |
| Elevated hypercoagulability markers in hemoglobin SC disease MP Colella, EV de Paula, JA Machado-Neto, N Conran, ... haematologica 100 (4), 466, 2015 | 47 | 2015 |
| Role of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studies BW Hounkpe, MML Fiusa, MP Colella, L Nilkenes Gomes da Costa, ... Scientific reports 5 (1), 17822, 2015 | 45 | 2015 |
| Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea FCM Lopes, F Traina, CB Almeida, FC Leonardo, CF Franco-Penteado, ... haematologica 100 (6), 730, 2015 | 40 | 2015 |
| Elevated plasma levels and platelet‐associated expression of the pro‐thrombotic and pro‐inflammatory protein, T NFSF14 (LIGHT), in sickle cell disease VT Garrido, R Proença‐Ferreira, VM Dominical, F Traina, MAC Bezerra, ... British journal of haematology 158 (6), 788-797, 2012 | 39 | 2012 |
| Safety and efficacy of cryoprecipitate‐poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: A single center retrospective … B Stefanello, EV De Paula, F Andrade Orsi, JF Comenalli Marques Jr, ... Journal of Clinical Apheresis 29 (6), 311-315, 2014 | 30 | 2014 |
| Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit ACN Barbosa, SAL Montalvão, KGN Barbosa, MP Colella, ... Research and practice in thrombosis and haemostasis 3 (4), 749-757, 2019 | 28 | 2019 |
| Guideline on immune thrombocytopenia in adults: associação Brasileira de hematologia, hemoterapia e terapia celular. Project guidelines: associação médica Brasileira–2018 MC Ozelo, MP Colella, EV de Paula, ACKV do Nascimento, PR Villaça, ... Hematology, transfusion and cell therapy 40, 50-74, 2018 | 27 | 2018 |
| Tissue factor-dependent coagulation activation by heme: A thromboelastometry study GR de Souza, BW Hounkpe, MML Fiusa, MP Colella, ... PloS one 12 (4), e0176505, 2017 | 26 | 2017 |
| Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban T Ferreira, SC Huber, B de Moraes Martinelli, AL Junior, FH Menezes, ... Vascular pharmacology 124, 106608, 2020 | 23 | 2020 |
| Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the … SS Medina, LH Siqueira, MP Colella, GG Yamaguti-Hayakawa, ... BMC pediatrics 17, 1-6, 2017 | 23 | 2017 |
| The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome S da Silva Saraiva, B de Moraes Mazetto, L Quinteiro Tobaldine, ... American journal of hematology 92 (11), 1163-1169, 2017 | 18 | 2017 |
| Telomere length correlates with disease severity and inflammation in sickle cell disease MP Colella, BA Santana, N Conran, V Tomazini, FF Costa, RT Calado, ... Revista brasileira de hematologia e hemoterapia 39 (2), 140-145, 2017 | 16 | 2017 |
| Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic MP Colella, MML Fiusa, FLA Orsi, EV de Paula, JM Annichino-Bizzacchi Blood coagulation & fibrinolysis 23 (2), 172-174, 2012 | 14 | 2012 |
| A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response MP Colella, FA Orsi, ECF Alves, GF Delmoro, GG Yamaguti‐Hayakawa, ... Journal of Thrombosis and Haemostasis 19 (9), 2275-2286, 2021 | 12 | 2021 |
| Residual vein thrombosis echogenicity is associated to the risk of DVT recurrence: a cohort study BM Mazetto, FLA Orsi, SAF Silveira, LF Bittar, MMC Flores-Nascimento, ... Clinical and Applied Thrombosis/Hemostasis 24 (3), 477-482, 2018 | 12 | 2018 |
| Haemostatic management of extreme challenges to haemostasis in acquired von Willebrand syndrome MP Colella, GC Duarte, JFC Marques Jr, EV De Paula Haemophilia 18 (3), e188-e191, 2012 | 12 | 2012 |
| Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome LQ Tobaldini, FT Arantes, S da Silva Saraiva, B de Moraes Mazetto, ... Thrombosis Research 171, 114-120, 2018 | 10 | 2018 |
